€174.85
1.69% today
Paris, Aug 25, 05:35 pm CET
ISIN
FR0013154002
Symbol
DIM

Sartorius Stedim Biotech Stock price

€177.85
+2.85 1.63% 1M
-26.55 12.99% 6M
-10.85 5.75% YTD
+2.45 1.40% 1Y
-204.65 53.50% 3Y
-124.35 41.15% 5Y
+134.57 310.90% 10Y
+173.90 4,402.53% 20Y
Paris, Closing price Fri, Aug 22 2025
+1.55 0.88%

Key metrics

Basic
Market capitalization
€17.2b
Enterprise Value
€19.4b
Net debt
€2.2b
Cash
€745.1m
Shares outstanding
97.3m
Valuation (TTM | estimate)
P/E
78.3 | 39.8
P/S
5.9 | 5.6
EV/Sales
6.7 | 6.4
EV/FCF
39.0
P/B
4.3
Dividends
DPS
€0.69
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
0.0% | 15.2%
Payout 1Y | 3Y
38.1% | 19.2%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€2.9b | €3.0b
EBITDA
€738.1m | €907.6m
EBIT
€426.0m | €620.4m
Net Income
€225.4m | €434.6m
Free Cash Flow
€496.5m
Growth (TTM | estimate)
Revenue
5.4% | 9.5%
EBITDA
8.6% | 29.8%
EBIT
7.5% | 56.0%
Net Income
33.2% | 148.2%
Free Cash Flow
62.8%
Margin (TTM | estimate)
Gross
44.6%
EBITDA
25.5% | 29.8%
EBIT
14.7%
Net
7.8% | 14.3%
Free Cash Flow
17.1%
Financial Health
Equity Ratio
48.3%
Return on Equity
4.4%
ROCE
5.8%
ROIC
5.0%
Debt/Equity
0.7
More
EPS
€2.3
FCF per Share
€5.1
Short interest
-
Employees
10k
Rev per Employee
€280.0k
Show more

Is Sartorius Stedim Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Sartorius Stedim Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Sartorius Stedim Biotech forecast:

15x Buy
83%
3x Hold
17%

Analyst Opinions

18 Analysts have issued a Sartorius Stedim Biotech forecast:

Buy
83%
Hold
17%

Financial data from Sartorius Stedim Biotech

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,896 2,896
5% 5%
100%
- Direct Costs 1,604 1,604
0% 0%
55%
1,293 1,293
13% 13%
45%
- Selling and Administrative Expenses 663 663
4% 4%
23%
- Research and Development Expense 146 146
8% 8%
5%
738 738
9% 9%
25%
- Depreciation and Amortization 312 312
10% 10%
11%
EBIT (Operating Income) EBIT 426 426
7% 7%
15%
Net Profit 225 225
33% 33%
8%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius Stedim Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sartorius Stedim Biotech Stock News

AD HOC NEWS
about one month ago
Sartorius Stedim Biotech SA / FR0013154002
AD HOC NEWS
about one month ago
Sartorius Stedim Biotech SA / FR0013154002
More Sartorius Stedim Biotech News

Company Profile

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions and focus on single-use technologies are supporting biopharma companies around the world to develop and produce drugs safely, timely and economically. The company's product portfolio include cell analysis, cell culture media and buffers, bioreactors fermenters, lab filtration & purification, process filtration & purification, fluid management, process control & data analytics, industrial microbiology, water purification, weighing, pipetting & dispensing OEM, centrifuges and lab catalogs. Sartorius Stedim Biotech was founded in 1978 and is headquartered in Aubagne, France.

Head office France
CEO René Fáber
Employees 9,961
Founded 1978
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today